Tag Archives: Multaq

The FDA and the Saga of Multaq – When is enough, enough?

There are growing safety concerns over the anti-arrhythmia drug Multaq, (dronedarone), which is manufactured and marketed by Sanofi-Aventis and has generated a great deal of controversy and concern in just a few short years. Multaq was first approved by the … Continue reading

Posted in Medical malpractice law | Tagged , , | Leave a comment